Cargando…

Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations

An estimated one quarter of persons worldwide are infected with Mycobacterium tuberculosis. In 2018, the World Health Organization issued revised guidance on BCG vaccine for high-risk groups. The World Health Organization should consider guiding countries on a case-by-case basis in developing approp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pooransingh, Shalini, Sakhamuri, Sateesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045831/ https://www.ncbi.nlm.nih.gov/pubmed/31922950 http://dx.doi.org/10.3201/eid2603.191232

Ejemplares similares

Beyond airflow obstruction: acknowledging the diversity of abnormal spirometry patterns
por: Sakhamuri, Sateesh, et al.
Publicado: (2023)

761. Age-Related Incidence of TB Infection Supporting Efficacy of BCG Vaccination
por: Sweeney, Eileen, et al.
Publicado: (2018)

Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries
por: Whittaker, Elizabeth, et al.
Publicado: (2018)

Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021)

Strengthening African health systems through global health diplomacy
por: Chattu, Vijay Kumar, et al.
Publicado: (2020)

The impact of air pollution on the incidence and mortality of COVID-19
por: Karan, Abhinav, et al.
Publicado: (2020)

Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population
por: Yang, Chin-Hui, et al.
Publicado: (2013)

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
por: Gunasena, Manuja, et al.
Publicado: (2022)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

What is the efficacy of BCG vaccination in the protection from COVID-19 in European countries?
por: Ghazvini, K., et al.
Publicado: (2021)

Calling on Latin America and the Caribbean countries to recognise the disability from long COVID
por: Sakhamuri, Sateesh M., et al.
Publicado: (2022)

MYCOBACTERIAL ABSCESSES AFTER BCG VACCINATION
por: Brennan, R, et al.
Publicado: (2019)

An Evaluation of a Modified CTAS at an Accident and Emergency Department in a Developing Country
por: Pooransingh, Shalini, et al.
Publicado: (2018)

A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities
por: Faust, Lena, et al.
Publicado: (2019)

TB infection and BCG vaccination: are we protected from COVID-19?
por: Madan, M., et al.
Publicado: (2020)

Commentary: Bettering BCG: a tough task for a TB vaccine?
por: Srivastava, Brahm S., et al.
Publicado: (2019)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Comparative Tuberculosis (TB) Prevention Effectiveness in Children of Bacillus Calmette-Guérin (BCG) Vaccines from Different Sources, Kazakhstan
por: Favorov, Michael, et al.
Publicado: (2012)

Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming
por: Gonçalves, Eduardo DC, et al.
Publicado: (2007)

Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
por: Thysen, Sanne M, et al.
Publicado: (2020)

‘Fight TB with BCG’: Mass Vaccination Campaigns in the British Caribbean, 1951–6
por: Altink, Henrice
Publicado: (2014)

Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)

The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
por: Pereira, Marcos, et al.
Publicado: (2020)

Determining the Need for Additional Testing With Quantiferon TB Gold in Patients With Positive Tuberculin Skin Tests and a History of BCG Vaccination
por: Arumairaj, Antony J, et al.
Publicado: (2023)

Osteomyelitis: An Uncommon Complication of BCG Vaccination
por: Pancharatnam, D, et al.
Publicado: (2021)

COVID-19 Death and BCG Vaccination
por: Wiwanitkit, Viroj
Publicado: (2021)

COVID-19 Highlights a Critical Need for Efficient Health Information Systems for Managing Epidemics of Emerging Infectious Diseases
por: Pooransingh, Shalini, et al.
Publicado: (2021)

Pre-Clinical Development of BCG.HIVA(CAT), an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2012)

Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease
por: Velayutham, Banurekha, et al.
Publicado: (2023)

Post-TB lung disease in three African countries
por: Binegdie, A. B., et al.
Publicado: (2022)

Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany
por: Marín-Hernández, Daniela, et al.
Publicado: (2021)

Vaccination-related Mycobacterium bovis BCG Infection
por: Liberek, Anna, et al.
Publicado: (2006)

Tokyo-172 BCG Vaccination Complications, Taiwan
por: Jou, Ruwen, et al.
Publicado: (2009)

Increase in Lymphadenitis Cases after Shift in BCG Vaccine Strain
por: Kuchukhidze, Giorgi, et al.
Publicado: (2015)

Engineering new mycobacterial vaccine design for HIV–TB pediatric vaccine vectored by lysine auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2014)

A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
por: Dijkman, Karin, et al.
Publicado: (2023)

Attributable is preventable: Corrected and revised estimates of population attributable fraction of TB related to undernutrition in 30 high TB burden countries
por: Bhargava, Anurag, et al.
Publicado: (2022)

Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews
por: Collin, Simon M., et al.
Publicado: (2019)

Social determinants and BCG efficacy: a call for a socio-biological approach to TB prevention
por: Dowd, Jennifer B., et al.
Publicado: (2018)

Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland
por: Sweeney, Eileen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gss09j7nkve684r9alf0gsm0b3